 | • レポートコード：MRC2102QY15298 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の旅行者用下痢治療薬市場について種類別（予防接種、非抗生物質、抗生物質、抗運動剤、その他）、用途別（成人旅行者用下痢止め、子供旅行者用下痢止め）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・旅行者用下痢治療薬市場の概要 ・世界の主要地域別旅行者用下痢治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の旅行者用下痢治療薬市場規模2015-2026：種類別（予防接種、非抗生物質、抗生物質、抗運動剤、その他） ・世界の旅行者用下痢治療薬市場規模2015-2026：用途別（成人旅行者用下痢止め、子供旅行者用下痢止め） ・旅行者用下痢治療薬の米国市場規模2015-2020 ・旅行者用下痢治療薬のヨーロッパ市場規模2015-2020 ・旅行者用下痢治療薬の中国市場規模2015-2020 ・旅行者用下痢治療薬の日本市場規模2015-2020 ・旅行者用下痢治療薬の東南アジア市場規模2015-2020 ・旅行者用下痢治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・旅行者用下痢治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・旅行者用下痢治療薬の市場動向・機会・課題 ・調査の結論 |
Traveler’s diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.
Market Analysis and Insights: Global Traveler’s Diarrhea Therapeutics Market
The global Traveler’s Diarrhea Therapeutics market size is projected to reach US$ 1182 million by 2026, from US$ 783.2 million in 2020, at a CAGR of 7.1% during 2021-2026.
Global Traveler’s Diarrhea Therapeutics Scope and Market Size
The global Traveler’s Diarrhea Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Traveler’s Diarrhea Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Traveler’s Diarrhea Therapeutics market is segmented into
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segment by Application, the Traveler’s Diarrhea Therapeutics market is segmented into
Adult Traveler’s Diarrhea
Children Traveler’s Diarrhea
The Traveler’s Diarrhea Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the Traveler’s Diarrhea Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Traveler’s Diarrhea Therapeutics Market Share Analysis
Traveler’s Diarrhea Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Traveler’s Diarrhea Therapeutics business, the date to enter into the Traveler’s Diarrhea Therapeutics market, Traveler’s Diarrhea Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
1 Traveler’s Diarrhea Therapeutics Market Overview
1.1 Traveler’s Diarrhea Therapeutics Product Scope
1.2 Traveler’s Diarrhea Therapeutics Segment by Type
1.2.1 Global Traveler’s Diarrhea Therapeutics Sales by Type (2020-2026)
1.2.2 Immunization
1.2.3 Non-antibiotic Agents
1.2.4 Antibiotics
1.2.5 Anti-Motility Agents
1.2.6 Others
1.3 Traveler’s Diarrhea Therapeutics Segment by Application
1.3.1 Global Traveler’s Diarrhea Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 Adult Traveler’s Diarrhea
1.3.3 Children Traveler’s Diarrhea
1.4 Traveler’s Diarrhea Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global Traveler’s Diarrhea Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global Traveler’s Diarrhea Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global Traveler’s Diarrhea Therapeutics Price Trends (2015-2026)
2 Traveler’s Diarrhea Therapeutics Estimate and Forecast by Region
2.1 Global Traveler’s Diarrhea Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Traveler’s Diarrhea Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Traveler’s Diarrhea Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global Traveler’s Diarrhea Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global Traveler’s Diarrhea Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Traveler’s Diarrhea Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Traveler’s Diarrhea Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Traveler’s Diarrhea Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe Traveler’s Diarrhea Therapeutics Estimates and Projections (2015-2026)
2.4.3 China Traveler’s Diarrhea Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan Traveler’s Diarrhea Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Traveler’s Diarrhea Therapeutics Estimates and Projections (2015-2026)
2.4.6 India Traveler’s Diarrhea Therapeutics Estimates and Projections (2015-2026)
3 Global Traveler’s Diarrhea Therapeutics Competition Landscape by Players
3.1 Global Top Traveler’s Diarrhea Therapeutics Players by Sales (2015-2020)
3.2 Global Top Traveler’s Diarrhea Therapeutics Players by Revenue (2015-2020)
3.3 Global Traveler’s Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Traveler’s Diarrhea Therapeutics as of 2019)
3.4 Global Traveler’s Diarrhea Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers Traveler’s Diarrhea Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Traveler’s Diarrhea Therapeutics Players (Opinion Leaders)
4 Global Traveler’s Diarrhea Therapeutics Market Size by Type
4.1 Global Traveler’s Diarrhea Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global Traveler’s Diarrhea Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global Traveler’s Diarrhea Therapeutics Price by Type (2015-2020)
4.2 Global Traveler’s Diarrhea Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Traveler’s Diarrhea Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Traveler’s Diarrhea Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global Traveler’s Diarrhea Therapeutics Price Forecast by Type (2021-2026)
5 Global Traveler’s Diarrhea Therapeutics Market Size by Application
5.1 Global Traveler’s Diarrhea Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global Traveler’s Diarrhea Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global Traveler’s Diarrhea Therapeutics Price by Application (2015-2020)
5.2 Global Traveler’s Diarrhea Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Traveler’s Diarrhea Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Traveler’s Diarrhea Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Traveler’s Diarrhea Therapeutics Price Forecast by Application (2021-2026)
6 United States Traveler’s Diarrhea Therapeutics Market Facts & Figures
6.1 United States Traveler’s Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
6.2 United States Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
6.3 United States Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
7 Europe Traveler’s Diarrhea Therapeutics Market Facts & Figures
7.1 Europe Traveler’s Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
7.2 Europe Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
7.3 Europe Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
8 China Traveler’s Diarrhea Therapeutics Market Facts & Figures
8.1 China Traveler’s Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
8.2 China Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
8.3 China Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
9 Japan Traveler’s Diarrhea Therapeutics Market Facts & Figures
9.1 Japan Traveler’s Diarrhea Therapeutics Sales Market Share by Company (3015-3030)
9.2 Japan Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
9.3 Japan Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
10 Southeast Asia Traveler’s Diarrhea Therapeutics Market Facts & Figures
10.1 Southeast Asia Traveler’s Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
11 India Traveler’s Diarrhea Therapeutics Market Facts & Figures
11.1 India Traveler’s Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
11.2 India Traveler’s Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
11.3 India Traveler’s Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Traveler’s Diarrhea Therapeutics Business
12.1 Salix Pharmaceuticals
12.1.1 Salix Pharmaceuticals Corporation Information
12.1.2 Salix Pharmaceuticals Business Overview
12.1.3 Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Salix Pharmaceuticals Traveler’s Diarrhea Therapeutics Products Offered
12.1.5 Salix Pharmaceuticals Recent Development
12.2 P&G
12.2.1 P&G Corporation Information
12.2.2 P&G Business Overview
12.2.3 P&G Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 P&G Traveler’s Diarrhea Therapeutics Products Offered
12.2.5 P&G Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Johnson & Johnson Traveler’s Diarrhea Therapeutics Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Otsuka Pharma
12.4.1 Otsuka Pharma Corporation Information
12.4.2 Otsuka Pharma Business Overview
12.4.3 Otsuka Pharma Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Otsuka Pharma Traveler’s Diarrhea Therapeutics Products Offered
12.4.5 Otsuka Pharma Recent Development
12.5 Valneva
12.5.1 Valneva Corporation Information
12.5.2 Valneva Business Overview
12.5.3 Valneva Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Valneva Traveler’s Diarrhea Therapeutics Products Offered
12.5.5 Valneva Recent Development
12.6 Shanghai United Cell
12.6.1 Shanghai United Cell Corporation Information
12.6.2 Shanghai United Cell Business Overview
12.6.3 Shanghai United Cell Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shanghai United Cell Traveler’s Diarrhea Therapeutics Products Offered
12.6.5 Shanghai United Cell Recent Development
12.7 PaxVax
12.7.1 PaxVax Corporation Information
12.7.2 PaxVax Business Overview
12.7.3 PaxVax Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 PaxVax Traveler’s Diarrhea Therapeutics Products Offered
12.7.5 PaxVax Recent Development
12.8 Livzon
12.8.1 Livzon Corporation Information
12.8.2 Livzon Business Overview
12.8.3 Livzon Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Livzon Traveler’s Diarrhea Therapeutics Products Offered
12.8.5 Livzon Recent Development
12.9 Immuron
12.9.1 Immuron Corporation Information
12.9.2 Immuron Business Overview
12.9.3 Immuron Traveler’s Diarrhea Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Immuron Traveler’s Diarrhea Therapeutics Products Offered
12.9.5 Immuron Recent Development
13 Traveler’s Diarrhea Therapeutics Manufacturing Cost Analysis
13.1 Traveler’s Diarrhea Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Traveler’s Diarrhea Therapeutics
13.4 Traveler’s Diarrhea Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Traveler’s Diarrhea Therapeutics Distributors List
14.3 Traveler’s Diarrhea Therapeutics Customers
15 Market Dynamics
15.1 Traveler’s Diarrhea Therapeutics Market Trends
15.2 Traveler’s Diarrhea Therapeutics Opportunities and Drivers
15.3 Traveler’s Diarrhea Therapeutics Market Challenges
15.4 Traveler’s Diarrhea Therapeutics Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Traveler's Diarrhea Therapeutics Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Traveler's Diarrhea Therapeutics Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Traveler's Diarrhea Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Region (2015-2020)
Table 5. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2015-2020)
Table 6. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Traveler's Diarrhea Therapeutics Revenue Share by Region (2015-2020)
Table 8. Global Traveler's Diarrhea Therapeutics Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Traveler's Diarrhea Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Traveler's Diarrhea Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 12. Global Traveler's Diarrhea Therapeutics (K Units) of Key Companies (2015-2020)
Table 13. Global Traveler's Diarrhea Therapeutics Sales Share by Company (2015-2020)
Table 14. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Traveler's Diarrhea Therapeutics Revenue Share by Company (2015-2020)
Table 16. Global Traveler's Diarrhea Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Traveler's Diarrhea Therapeutics as of 2019)
Table 17. Global Traveler's Diarrhea Therapeutics Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Traveler's Diarrhea Therapeutics Manufacturing Sites and Area Served
Table 19. Manufacturers Traveler's Diarrhea Therapeutics Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Traveler's Diarrhea Therapeutics Players
Table 22. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 23. Global Traveler's Diarrhea Therapeutics Sales Share by Type (2015-2020)
Table 24. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Traveler's Diarrhea Therapeutics Price (K Units) by Type (2015-2020)
Table 26. Global Traveler's Diarrhea Therapeutics Sales Share by Type (2021-2026)
Table 27. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Traveler's Diarrhea Therapeutics Revenue Share by Type (2021-2026)
Table 29. Global Traveler's Diarrhea Therapeutics Price (K Units) by Type (2021-2026)
Table 30. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2015-2020)
Table 31. Global Traveler's Diarrhea Therapeutics Sales Share by Application (2015-2020)
Table 32. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Traveler's Diarrhea Therapeutics Price (K Units) by Application (2015-2020)
Table 34. Global Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2021-2026)
Table 35. Global Traveler's Diarrhea Therapeutics Sales Share by Application (2021-2026)
Table 36. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Traveler's Diarrhea Therapeutics Revenue Share by Application (2021-2026)
Table 38. Global Traveler's Diarrhea Therapeutics Price (K Units) by Application (2021-2026)
Table 39. United States Traveler's Diarrhea Therapeutics Sales (K Units) by Company (2015-2020)
Table 40. United States Traveler's Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
Table 41. United States Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 42. United States Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 43. United States Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2015-2020)
Table 44. United States Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
Table 45. Europe Traveler's Diarrhea Therapeutics Sales (K Units) by Company (2015-2020)
Table 46. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
Table 47. Europe Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 48. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 49. Europe Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2015-2020)
Table 50. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 51. China Traveler's Diarrhea Therapeutics Sales (K Units) by Company (2015-2020)
Table 52. China Traveler's Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
Table 53. China Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 54. China Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 55. China Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2015-2020)
Table 56. China Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
Table 57. Japan Traveler's Diarrhea Therapeutics Sales (K Units) by Company (2015-2020)
Table 58. Japan Traveler's Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
Table 59. Japan Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 60. Japan Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 61. Japan Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2015-2020)
Table 62. Japan Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Traveler's Diarrhea Therapeutics Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Traveler's Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
Table 69. India Traveler's Diarrhea Therapeutics Sales (K Units) by Company (2015-2020)
Table 70. India Traveler's Diarrhea Therapeutics Sales Market Share by Company (2015-2020)
Table 71. India Traveler's Diarrhea Therapeutics Sales (K Units) by Type (2015-2020)
Table 72. India Traveler's Diarrhea Therapeutics Sales Market Share by Type (2015-2020)
Table 73. India Traveler's Diarrhea Therapeutics Sales (K Units) by Application (2015-2020)
Table 74. India Traveler's Diarrhea Therapeutics Sales Market Share by Application (2015-2020)
Table 75. Salix Pharmaceuticals Corporation Information
Table 76. Salix Pharmaceuticals Description and Business Overview
Table 77. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product
Table 79. Salix Pharmaceuticals Recent Development
Table 80. P&G Corporation Information
Table 81. P&G Description and Business Overview
Table 82. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. P&G Traveler's Diarrhea Therapeutics Product
Table 84. P&G Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Traveler's Diarrhea Therapeutics Product
Table 89. Johnson & Johnson Recent Development
Table 90. Otsuka Pharma Corporation Information
Table 91. Otsuka Pharma Description and Business Overview
Table 92. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Otsuka Pharma Traveler's Diarrhea Therapeutics Product
Table 94. Otsuka Pharma Recent Development
Table 95. Valneva Corporation Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Valneva Traveler's Diarrhea Therapeutics Product
Table 99. Valneva Recent Development
Table 100. Shanghai United Cell Corporation Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Shanghai United Cell Traveler's Diarrhea Therapeutics Product
Table 104. Shanghai United Cell Recent Development
Table 105. PaxVax Corporation Information
Table 106. PaxVax Description and Business Overview
Table 107. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. PaxVax Traveler's Diarrhea Therapeutics Product
Table 109. PaxVax Recent Development
Table 110. Livzon Corporation Information
Table 111. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Livzon Description and Business Overview
Table 113. Livzon Traveler's Diarrhea Therapeutics Product
Table 114. Livzon Recent Development
Table 115. Immuron Corporation Information
Table 116. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Immuron Description and Business Overview
Table 118. Immuron Traveler's Diarrhea Therapeutics Product
Table 119. Immuron Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Traveler's Diarrhea Therapeutics Distributors List
Table 123. Traveler's Diarrhea Therapeutics Customers List
Table 124. Traveler's Diarrhea Therapeutics Market Key Trends
Table 125. Traveler's Diarrhea Therapeutics Key Opportunities and Drivers
Table 126. Traveler's Diarrhea Therapeutics Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Traveler's Diarrhea Therapeutics Product Picture
Figure 2. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Traveler's Diarrhea Therapeutics Market Share by Application in 2020 & 2026
Figure 6. Adult Traveler's Diarrhea Examples
Figure 7. Children Traveler's Diarrhea Examples
Figure 8. Global Traveler's Diarrhea Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Traveler's Diarrhea Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Traveler's Diarrhea Therapeutics Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Traveler's Diarrhea Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Traveler's Diarrhea Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Traveler's Diarrhea Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Traveler's Diarrhea Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Traveler's Diarrhea Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Traveler's Diarrhea Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Traveler's Diarrhea Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Traveler's Diarrhea Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Traveler's Diarrhea Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Traveler's Diarrhea Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Traveler's Diarrhea Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Traveler's Diarrhea Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Traveler's Diarrhea Therapeutics Players Market Share by Revenue in Traveler's Diarrhea Therapeutics 2015 & 2019
Figure 26. Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Traveler's Diarrhea Therapeutics Revenue Share by Type (2015-2020)
Figure 28. Global Traveler's Diarrhea Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Traveler's Diarrhea Therapeutics Revenue Share by Application (2015-2020)
Figure 30. Global Traveler's Diarrhea Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 32. United States Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 33. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2019
Figure 34. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 35. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2019
Figure 36. China Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2019
Figure 37. China Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 38. China Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2019
Figure 39. Japan Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2019
Figure 40. Japan Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 41. Japan Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2019
Figure 42. Southeast Asia Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2019
Figure 43. Southeast Asia Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 44. Southeast Asia Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2019
Figure 45. India Traveler's Diarrhea Therapeutics Sales Market Share by Company in 2019
Figure 46. India Traveler's Diarrhea Therapeutics Sales Market Share by Type in 2019
Figure 47. India Traveler's Diarrhea Therapeutics Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Traveler's Diarrhea Therapeutics
Figure 50. Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics
Figure 51. Traveler's Diarrhea Therapeutics Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
下痢同伴過敏性腸症候群（IBS-D）治療薬の世界市場レポート2020 Rifaximin (Xifaxan) is an antibiotic medication for IBS-D that works by reducing or altering gut bacteria, and it can improve symptoms of bloating and diarrhea after a 10 to 14 day course of treatment. Some patients require retreatment at higher doses for symptom relief. Market Analysis and Insights…- ワルデンシュトレームマクログロブリン血症（WM）治療の世界市場レポート2020 Market Analysis and Insights: Global Waldenstrom Macroglobulinemia Therapeutics Market The global Waldenstrom Macroglobulinemia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Waldenstrom Macroglobulinemia …
- 泌尿器がん治療薬の世界市場レポート2020 Global Urological Cancer Therapeutics Drugs Market is estimated to reach $48.6 billion by 2025 Says, .Now a days urological cancers became very common worldwide and causing higher mortality rates. Specially in the case of kidney cancers, that illustrates the new therapeutic targets. Urological cance…
- 乳がん治療薬の世界市場レポート2020 Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara) for postmenopausal women. Side effects can include hot flashes and vaginal dryness Market Analysis and Insights: Global…
- ペプチド抗生物質の世界市場レポート2020 Market Analysis and Insights: Global Peptide Antibiotics Market The global Peptide Antibiotics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Peptide Antibiotics Scope and Market Size The global Peptide Antibiotics mar…